[HTML][HTML] Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du, H Zhou… - Cardiovascular …, 2022 - Springer
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis.
R Zou, W Shi, J Qiu, N Zhou, N Du… - Cardiovascular …, 2022 - search.ebscohost.com
Background: Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
[HTML][HTML] Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du, H Zhou… - Cardiovascular …, 2022 - ncbi.nlm.nih.gov
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis.
R Zou, W Shi, J Qiu, N Zhou, N Du, H Zhou… - Cardiovascular …, 2022 - europepmc.org
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du… - Cardiovascular …, 2022 - search.proquest.com
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
[HTML][HTML] Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du… - Cardiovascular …, 2022 - cardiab.biomedcentral.com
Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes
status. However, the role of empagliflozin in microvascular protection during myocardial …
status. However, the role of empagliflozin in microvascular protection during myocardial …
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du… - Cardiovascular …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …
[PDF][PDF] Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis
R Zou, W Shi, J Qiu, N Zhou, N Du, H Zhou, X Chen… - 2022 - cardiab.biomedcentral.com
Background: Empagliflozin has been reported to protect endothelial cell function, regardless
of diabetes status. However, the role of empagliflozin in microvascular protection during …
of diabetes status. However, the role of empagliflozin in microvascular protection during …